MyD88 in osteoclast and osteoblast lineages differentially controls bone remodeling in homeostasis and malaria
International Immunology · 2024
DOI: 10.1093/intimm/dxae023 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunology, 2024. Verfasst von Jalal Alshaweesh und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Malaria Immunology, Department of Microbiology and Immunology, The Institute of Medical Science (IMSUT), The University of Tokyo, Tokyo 1…. Hauptthemen laut MEDLINE: Myeloid Differentiation Factor 88, Malaria, Osteoblasts, Osteoclasts. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Japan Science and Technology Agency CREST program, Grant-in-Aid for Early-Career Scientists, Japan Agency for Medical Research and Development (AMED) Strategic Center of Biomedical Advanced Vaccine Research and Development for Preparedness and Response.
Abstract (Originalsprache)
Chronic bone loss is an under-recognized complication of malaria, the underlying mechanism of which remains incompletely understood. We have previously shown that persistent accumulation of Plasmodium products in the bone marrow leads to chronic inflammation in osteoblast (OB) and osteoclast (OC) precursors causing bone loss through MyD88, an adaptor molecule for diverse inflammatory signals. However, the specific contribution of MyD88 signaling in OB or OC precursors in malaria-induced bone loss remains elusive. To assess the direct cell-intrinsic role of MyD88 signaling in adult bone metabolism under physiological and infection conditions, we used the Lox-Cre system to specifically deplete MyD88 in the OB or OC lineages. Mice lacking MyD88 primarily in the maturing OBs showed a comparable decrease in trabecular bone density by microcomputed tomography to that of controls after Plasmodium yoelii non-lethal infection. In contrast, mice lacking MyD88 in OC precursors showed significantly less trabecular bone loss than controls, suggesting that malaria-mediated inflammatory mediators are primarily controlled by MyD88 in the OC lineage. Surprisingly, however, depletion of MyD88 in OB, but not in OC, precursors resulted in reduced bone mass with decreased bone formation rates in the trabecular areas of femurs under physiological conditions. Notably, insulin-like growth factor-1, a key molecule for OB differentiation, was significantly lower locally and systemically when MyD88 was depleted in OBs. Thus, our data demonstrate an indispensable intrinsic role for MyD88 signaling in OB differentiation and bone formation, while MyD88 signaling in OC lineages plays a partial role in controlling malaria-induced inflammatory mediators and following bone pathology. These findings may lead to the identification of novel targets for specific intervention of bone pathologies, particularly in malaria-endemic regions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Malaria Immunology, Department of Microbiology and Immunology, The Institute of Medical Science (IMSUT), The University of Tokyo, Tokyo 108-8639, Japan.
- International Vaccine Design Center, IMSUT, The University of Tokyo, Tokyo 108-8639, Japan.
- The University of Tokyo Pandemic Preparedness, Infection and Advanced Research Center (UTOPIA), The University of Tokyo, Tokyo 108-8639, Japan.
- Department of Computational Biology and Medical Science (CBMS), Graduate School of Frontier Sciences, University of Tokyo, Tokyo 108-8639, Japan.
- Immunology Frontier Research Center (IFReC), Osaka University, Osaka 565-0871, Japan.
- Department of Paediatrics, Hacettepe University School of Medicine, Ankara 06100, Turkey.
ORCID-Profile: Ken J Ishii, Cevayir Coban
Förderung
- Japan Science and Technology Agency CREST program
- Grant-in-Aid for Early-Career Scientists
- Japan Agency for Medical Research and Development (AMED) Strategic Center of Biomedical Advanced Vaccine Research and Development for Preparedness and Response
- International Joint Usage/Research Center
- Institute of Medical Science, University of Tokyo
- WINGS-GSDM 2.0
- JST SPRING GX
- Ito Foundation
Zitieren
APA
Alshaweesh, J., Dash, R., Lee, M. S. J., Kahyaoglu, P., Erci, E., Xu, M., Matsuo-Dapaah, J., Del Rosario Zorrilla, C., Aykac, K., Ekemen, S., Kobiyama, K., Ishii, K. J., & Coban, C. (2024). MyD88 in osteoclast and osteoblast lineages differentially controls bone remodeling in homeostasis and malaria. International Immunology. https://doi.org/10.1093/intimm/dxae023
Vancouver
Alshaweesh J, Dash R, Lee MSJ, Kahyaoglu P, Erci E, Xu M, et al. MyD88 in osteoclast and osteoblast lineages differentially controls bone remodeling in homeostasis and malaria. International Immunology. 2024. doi:10.1093/intimm/dxae023
BibTeX
@article{Alshaweesh2024,
author = {Alshaweesh, Jalal and Dash, Rashmi and Lee, Michelle S J and Kahyaoglu, Pinar and Erci, Ece and Xu, Mengling and Matsuo-Dapaah, Julia and Del Rosario Zorrilla, Camila and Aykac, Kubra and Ekemen, Suheyla and Kobiyama, Kouji and Ishii, Ken J and Coban, Cevayir},
title = {MyD88 in osteoclast and osteoblast lineages differentially controls bone remodeling in homeostasis and malaria},
journal = {International Immunology},
year = {2024},
doi = {10.1093/intimm/dxae023}
}
EUVIMED